{"id":1478,"date":"2013-05-21T15:13:57","date_gmt":"2013-05-21T15:13:57","guid":{"rendered":"\/?p=1478"},"modified":"2013-05-21T15:14:23","modified_gmt":"2013-05-21T15:14:23","slug":"nanoviricides-inc-otcbbnnvc-rises-after-promotion","status":"publish","type":"post","link":"\/articles\/nanoviricides-inc-otcbbnnvc-rises-after-promotion\/","title":{"rendered":"NanoViricides, Inc. (OTCBB:NNVC) Rises After Promotion"},"content":{"rendered":"

\"NNVCchart.png\"NanoViricides, Inc. (OTCBB:NNVC<\/a>) started the week strong by gaining more than 12% to close at $0.62. Intraday high went as far as $0.67 but took a step back at closing time. The volume of traded shares also exploded reaching nearly 1 million – ten times more than what the previous session saw. <\/p>\n

NNVC<\/a> is a development-stage company that trying to create a special purpose nanomaterials for viral therapy. They have targeted a wide range of viral diseases in the likes of swine flu, bird flu, seasonal Influenza, HIV, Hepatitis C, and the Ebola virus. <\/p>\n

Despite being relatively high priced, the ticker has seen its fair share of volatility. In late February it dropped to $0.32 just to double in value a week later. Since then the stock has been fluctuating a lot but never reaching such drastic movements.<\/p>\n

On the financial side of things NNVC<\/a> is leagues ahead of most of the other pennystock development-stage companies. In their latest quarterly report for the period ending March 31 they disclosed :<\/p>\n